372320 — Curocell Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for Curocell, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	—	—	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	—	-53,576	-38,885	-29,575	-38,238
Depreciation
Amortisation
Non-Cash Items	—	41,448	21,109	372	4,705
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-6,885	-1,123	1,557	-767	-1,224
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-6,885	-11,536	-14,392	-25,264	-28,422
Capital Expenditures	-3,577	-9,299	-27,870	-21,650	-1,210
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-30,643	17,794	-12,851	524	23,230
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-34,220	8,495	-40,721	-21,127	22,020
Financing Cash Flow Items	—	-18.2	—	—	-6.82
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	43,666	42,224	19,148	49,682	1,042
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	2,561	39,183	-35,964	3,291	-5,337